Literature DB >> 15172947

Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders.

Gavin Andrews1, Cathy Issakidis, Kristy Sanderson, Justine Corry, Helen Lapsley.   

Abstract

BACKGROUND: Mental health survey data are now being used proactively to decide how the burden of disease might best be reduced. AIMS: To study the cost-effectiveness of current and optimal treatments for mental disorders and the proportion of burden avertable by each.
METHOD: Data for three affective, four anxiety and two alcohol use disorders and for schizophrenia were compared interms of cost, burden averted and efficiency of current and optimal treatment. We then calculated the burden unavertable given current knowledge. The unit of health gain was a reduction in the years lived with disability (YLDs).
RESULTS: Summing across all disorders, current treatment averted 13% of the burden, at an average cost of 30,000 Australian dollars per YLD gained. Optimal treatment at current coverage could avert 20% of the burden, at an average cost of 18,000 Australian dollars per YLD gained. Optimal treatment at optimal coverage could avert 28% of the burden, at 16,000 Australian dollars per YLD gained. Sixty per cent of the burden of mental disorders was deemed to be unavertable.
CONCLUSIONS: The efficiency of treatment varied more than tenfold across disorders. Although coverage of some of the more efficient treatments should be extended, other factors justify continued use of less-efficient treatments for some disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15172947     DOI: 10.1192/bjp.184.6.526

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  139 in total

Review 1.  Sleep disturbance, inflammation and depression risk in cancer survivors.

Authors:  Michael R Irwin; Richard E Olmstead; Patricia A Ganz; Reina Haque
Journal:  Brain Behav Immun       Date:  2012-05-24       Impact factor: 7.217

2.  The future of psychotherapy research: stop the waste and focus on issues that matter.

Authors:  P Cuijpers
Journal:  Epidemiol Psychiatr Sci       Date:  2015-09-09       Impact factor: 6.892

3.  Diagnosis and management of patients with bipolar disorder in primary care.

Authors:  Michael Berk; Seetal Dodd; Lesley Berk; Jane Opie
Journal:  Br J Gen Pract       Date:  2005-09       Impact factor: 5.386

4.  Association of Midlife Cardiorespiratory Fitness With Incident Depression and Cardiovascular Death After Depression in Later Life.

Authors:  Benjamin L Willis; David Leonard; Carolyn E Barlow; Scott B Martin; Laura F DeFina; Madhukar H Trivedi
Journal:  JAMA Psychiatry       Date:  2018-09-01       Impact factor: 21.596

5.  Experience base and system context in mental health care reform.

Authors:  Thomas Becker; Reinhold Kilian
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

6.  Requisite models for strategic commissioning: the example of type 1 diabetes.

Authors:  Mara Airoldi; Gwyn Bevan; Alec Morton; Mónica Oliveira; Jenifer Smith
Journal:  Health Care Manag Sci       Date:  2008-06

7.  Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults.

Authors:  Eun Lee; Hyong Jin Cho; Richard Olmstead; Myron J Levin; Michael N Oxman; Michael R Irwin
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

8.  Prevention of depressive disorders: a brave new world.

Authors:  Charles F Reynolds
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 9.  Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review.

Authors:  Kirsten M van Steenbergen-Weijenburg; Christina M van der Feltz-Cornelis; Eva K Horn; Harm W J van Marwijk; Aartjan T F Beekman; Frans F H Rutten; Leona Hakkaart-van Roijen
Journal:  BMC Health Serv Res       Date:  2010-01-19       Impact factor: 2.655

10.  Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial.

Authors:  Filip Smit; Godelief Willemse; Peter Meulenbeek; Marc Koopmanschap; Anton van Balkom; Philip Spinhoven; Pim Cuijpers
Journal:  Cost Eff Resour Alloc       Date:  2009-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.